MONITORING OF ADVERSE REACTIONS TO PENICILLINS IN PATIENTS OF HEALTHCARE INSTITUTIONS IN THE CITY OF KHARKIV AND KHARKIV REGION

Keywords: pharmacovigilance, adverse reactions, notification cards, antibacterial drugs, penicillins

Abstract

Aim. The paper aims at analyzing the state of monitoring of adverse reactions to penicillins based on spontaneous reports of the pharmacovigilance system of Ukraine, received from healthcare institutions of Kharkiv region and the city of Kharkiv during 2017-2019.

Materials and Methods. The objects of the study included maps-reports of adverse reactions to the use of penicillins, which came from health care facilities of Kharkiv region and the city of Kharkiv to the pharmacovigilance system of Ukraine during 2017-2019. Information on adverse drug reactions was obtained using the method of collecting spontaneous messages in mixed form (paper and electronic versions).

Results. The analysis revealed that among the 6 INNs of the penicillin group, the largest number of adverse reactions were registered for amoxicillin / clavulanic acid (in 2017 - 73% of message cards, in 2018 - 54% of message cards, in 2019 - 70% of message cards). In the number of reports amoxicillin drugs ranked second place (in 2017 - 22% of card-messages, in 2018 - 43% of card-messages, in 2019 - 27% of card-messages).

Discussion. The recorded adverse reactions are not serious and most frequently manifested in the form of local reactions: itching, swelling and redness of the skin, as well as from the gastrointestinal tract: diarrhea and nausea. No serious adverse reactions with lethal outcome were reported.

Conclusions. The conducted monitoring confirmed the literature data on typical adverse reactions to antibiotics of the penicillin group. It has been established that penicillin-type antibiotics, namely amoxicillin/clavulanic acid and amoxicillin, have a high risk of adverse reactions as they are prescribed more frequently.

References

Blumental K. G. Antibiotic allergy. Lancet. 2019; 393 (10167): 183-198.

Viktorov A. P., Lohvina I. A., Matveeva E. V., Posokhova K. A. Penicillin safety ARoblems. Clinical immunology, allergology. 2007; 1 (06): 36-38.

Viktorov O. P. Safety of antibiotics in medical use. Rational pharmacotherapy. 2010; 4 (17): 26-31.

Viktorov O.P., Matveeva O.V., Derimedvid L.V. Pharmacovigilance. Pharmaceutical encyclopedia. 2021. URL: https://www.pharmencyclopedia.com.ua/article/297/farmakonaglyad

Drogovoz S. M. Side effects of drugs. Kharkov: SIM, 2010.

Drogovoz S. M., Shtryhol S. Yu., Shchekina E. H. Pharmacology to help the student, pharmacist and doctor. Kharkov: Titul, 2016.

Iakovlieva L. V., Matiashova N. O. Analysis of outpatient consumption of penicillin antibiotics in Ukraine. Pharmaceutical Journal. 2013. 1: 26-31.

Kraidashenko O. V., Belenichev I. F., Stets R. V. et al. Monitoring of adverse drug reactions is an important task of pharmacovigilance. Analysis of the work of the Zaporizhia regional branch of the SEC of the Ministry of Health of Ukraine. Current issues of pharmaceutical and medical science and ARactice. 2017; 1: 92-96.

Mostovoi Yu. M., Demchuk A. V. Retrospective assessment of the use of penicillins and cephalosporins in Ukraine. Ukrainian Chemotherapy Journal. 2012. 1-2 (25): 27-32.

Pongdee T, Li Mayo J.T. Clin. Evaluation and Management of Penicillin Allergy. ARoc. 2018 Jan; 93(1):101-107. doi: 10.1016/j.mayocp.2017.09.020.

WHO Regional Office for Europe. Antimicrobial Consumption Network. Antimicrobial consumption data for 2011-2014. 2015; 168 s.

Wong D., Duin D. Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy. Drugs. 2017 AAR; 77(6): 615-628.

Published
2021-12-23
How to Cite
Butko, Y., Melenchenko, N., Tkachova, O., & Kostyuchenko, T. (2021). MONITORING OF ADVERSE REACTIONS TO PENICILLINS IN PATIENTS OF HEALTHCARE INSTITUTIONS IN THE CITY OF KHARKIV AND KHARKIV REGION. Acta Medica Leopoliensia, 27(3-4), 150-159. https://doi.org/10.25040/aml2021.3-4.150